<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sayeli Vinaykumar</style></author><author><style face="normal" font="default" size="100%">Urval Pundarik Rathnakar</style></author><author><style face="normal" font="default" size="100%">Ullal Sheetal Dinkar</style></author><author><style face="normal" font="default" size="100%">Kamath Priyanka</style></author><author><style face="normal" font="default" size="100%">Tiwary Gaurav</style></author><author><style face="normal" font="default" size="100%">Shenoy Ashok Kudgi</style></author><author><style face="normal" font="default" size="100%">Revappala Sekhar Nishith</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Anti-inflammatory activity of BCM-95 (bio-enhanced formulation of turmeric with increased bioavailabilty) compared to Curcumin in Wistar rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anti-Inflammatory agents</style></keyword><keyword><style  face="normal" font="default" size="100%">Bioavailability</style></keyword><keyword><style  face="normal" font="default" size="100%">Curcumin</style></keyword><keyword><style  face="normal" font="default" size="100%">Inflammation</style></keyword><keyword><style  face="normal" font="default" size="100%">Wistar rats.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June/2016</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">8</style></volume><pages><style face="normal" font="default" size="100%">380-384</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align:justify&quot;&gt;&lt;strong&gt;Objective&lt;/strong&gt;: To evaluate anti-inflammatory activity of bioenhanced turmeric formulation (BCM-95) compared to commercial Curcumin formulation (Curcuminoids 95%) in Carrageenan-induced acute inflammatory model. &lt;strong&gt;Materials and Methods&lt;/strong&gt;: Thirty six Wistar rats were divided into six groups-Normal control (2 ml of vehicle), Standard control (Indomethacin 10 mg/kg), 2 doses of BCM 95 (10 and 20 mg/kg) and Curcuminoids 95% (10 and 20 mg/kg). Paw volume was measured using a digital plethysmometer. Vehicle or test drugs were given to rats 30 min before carrageenan administration. Baseline paw volume reading (V&lt;sub&gt;0&lt;/sub&gt;) was noted just prior to administration of 0.1 ml of 1% carrageenan to right hind paw of the rat. Test paw volume readings (V&lt;sub&gt;t&lt;/sub&gt;) were measured at 30, 60, 120, 180, 240, 300 and 360 min, after carrageenan injection. Oedema expressed as increased paw volume (v&lt;sub&gt;t&lt;/sub&gt;-v&lt;sub&gt;0&lt;/sub&gt;) was noted and percentage inhibition of oedema was calculated for all treatment groups. &lt;strong&gt;Statistical analysis&lt;/strong&gt;: Difference between groups were analyzed with ANOVA followed by Tukey test. &lt;strong&gt;Results:&lt;/strong&gt; All treatment groups demonstrated significant (p&amp;lt;0.05) anti-inflammatory activity (oedema suppression) compared to normal control&lt;strong&gt;. &lt;/strong&gt;Anti-inflammatory activity of BCM 95 treated groups were comparable to standard control group except at certain time points, whereas the same activity at all-time points with Curcuminoid 95% treated groups were significantly less than standard control group. Percentage inhibition of paw oedema was maximum with standard control group followed by BCM 95 treated groups followed by Curcuminoid 95% treated groups. &lt;strong&gt;Conclusion:&lt;/strong&gt; BCM 95 treated groups showed significant anti-inflammatory activity compared to Curcuminoid 95% treated groups.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">380</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Sayeli Vinaykumar&lt;sup&gt;1&lt;/sup&gt;, Urval Pundarik Rathnakar&lt;sup&gt;2&lt;/sup&gt;, Ullal Sheetal Dinkar&lt;sup&gt;1&lt;/sup&gt;*, Kamath Priyanka&lt;sup&gt;1&lt;/sup&gt;, Tiwary Gaurav&lt;sup&gt;1&lt;/sup&gt;, Ashok Shenoy Kudgi&lt;sup&gt;1&lt;/sup&gt;, Revappala Sekhar Nishith&lt;sup&gt;3&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmacology, Kasturba Medical College, Mangaluru, Manipal University, Manipal, INDIA.&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Pharmacology, Kanachur Institute of Medical Sciences, Deralakatte, Mangaluru. 575018, INDIA.&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Scoop Med Inc, Bengaluru, INDIA.&lt;/p&gt;
</style></auth-address></record></records></xml>